The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Design Therapeutics, Inc(NASDAQ:DSGN) 
Design Therapeutics, Inc. develops therapies for the treatment of degenerative disorders caused by nucleotide repeat expansions. The company engages in the development of a program for the treatment of Friedreich's ataxia and degenerative diseases such as Fragile X syndrome and myotonic dystrophy. T...
Share this website to your friends
Design Therapeutics Days Payable Outstanding ttm (DPO)
Design Therapeutics Days Receivable Outstanding ttm (DSO)
Design Therapeutics Days Inventory Outstanding ttm (DIO)
Design Therapeutics Op Cashflow Per Share ttm
Design Therapeutics Free Cashflow Per Share ttm
Design Therapeutics Cash Per Share ttm
Design Therapeutics P/S ratio ttm
Design Therapeutics (GAAP) P/E ratio ttm
Design Therapeutics P/B ratio ttm
No extra charts and metrics for this ticker.